Focus on JNJ-Q2, a novel fluoroquinolone, for the management of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections

JNJ-Q2 is a novel, fifth-generation fluoroquinolone that has excellent in vitro and in vivo activity against a variety of Gram-positive and Gram-negative organisms. In vitro studies indicate that JNJ-Q2 has potent activity against pathogens responsible for acute bacterial skin and skin structure inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, Travis M, Johnson, Steven W, DiMondi, V Paul, Wilson, Dustin T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908938/
https://www.ncbi.nlm.nih.gov/pubmed/27354817
http://dx.doi.org/10.2147/IDR.S105620

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908938/
https://www.ncbi.nlm.nih.gov/pubmed/27354817
http://dx.doi.org/10.2147/IDR.S105620

Ejemplares similares